Site Reference ID/Investigator# 4553 — Pico Rivera, California

Site Reference ID/Investigator# 4553 is a clinical research site located in Pico Rivera, California, United States 90660.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 4553 has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: Abbott.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pico Rivera

Browse all research sites in California · View every site in Pico Rivera

• CNRI-Los Angeles
• Research Site
• Alkermes Investigational Site
• Neurocrine Clinical Site
• GSK Investigational Site
• California Neuropsychopharmacology Clinical Research Institute
• California Neuropsychopharmacology Clinical Research Institute-LA, LLC
• CNRI - Los Angeles LLC,8309 Telegraph Road
• Pfizer Investigational Site
• California Neuropsychopharmacology Clinical Research Institute (CNRI), LLC
• Clinical Site
• CNRI-LA

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 4553?

Site Reference ID/Investigator# 4553 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 4553 conducted?

Site Reference ID/Investigator# 4553 has 1 clinical trials on record. Their work covers Schizophrenia.

Is Site Reference ID/Investigator# 4553 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 4553 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 4553?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.